Evidence map›Paper›PMID 35352813›Full record

ArticleEuropean heart journal2022

Importance of genetic testing in unexplained cardiac arrest.

Steffany Grondin, Brianna Davies, Julia Cadrin-Tourigny, Christian Steinberg, Christopher C Cheung, Paloma Jorda, Jeffrey S Healey, Martin S Green, Shubhayan Sanatani, Wael Alqarawi and 20 more

Open access · greenAbstract read
In one paragraph

Article in European heart journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Autopsy of all young sudden death cases is important to increase survival in family members left behind.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Review
  15. Idiopathic ventricular fibrillation: is it a case for genetic testing?Herzschrittmachertherapie & Elektrophysiologie · 2024
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. The genetic basis of apparently idiopathic ventricular fibrillation: a retrospective overview.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 15 institutions in 2 countries.

Steffany GrondinCardiovascular Genetics Center, Montreal Heart Institute, Department of Medicine, Université de Montréal, 5000 Belanger, Montreal, QC, Canada H1T 1C8.ORCID 0000-0002-7556-7672
Brianna DaviesCenter for Cardiovascular Innovation, Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-9469-7109
Julia Cadrin-TourignyCardiovascular Genetics Center, Montreal Heart Institute, Department of Medicine, Université de Montréal, 5000 Belanger, Montreal, QC, Canada H1T 1C8.ORCID 0000-0002-7489-8744
Christian SteinbergInstitut universitaire de cardiologie et pneumologie de Québec, Université Laval, Québec City, QC, Canada.ORCID 0000-0003-4112-0028
Christopher C CheungCenter for Cardiovascular Innovation, Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0003-0459-3897
Paloma JordaCardiovascular Genetics Center, Montreal Heart Institute, Department of Medicine, Université de Montréal, 5000 Belanger, Montreal, QC, Canada H1T 1C8.ORCID 0000-0002-9236-1713
Jeffrey S HealeyPopulation Health Research Institute, McMaster University, and Hamilton Health Sciences, Hamilton, ON, Canada.ORCID 0000-0003-1216-7580
Martin S GreenDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.ORCID 0000-0001-5486-9084
Shubhayan SanataniDivision of Pediatric Cardiology, British Columbia Children's Hospital, Vancouver, BC, Canada.ORCID 0000-0001-9296-7400
Wael AlqarawiDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.ORCID 0000-0001-5324-6993
Paul AngaranCardiac Arrhythmia Service, St Michael's Hospital, Toronto, ON, Canada.ORCID 0000-0003-2697-173X
Laura ArbourDepartment of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-9589-0880
Pavel AntiperovitchSection of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, ON, Canada.ORCID 0000-0002-8814-9015
Habib KhanSection of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, ON, Canada.
Richard LeatherDivision of Cardiology, Royal Jubilee Hospital, Victoria, BC, Canada.
Peter G GuerraCardiovascular Genetics Center, Montreal Heart Institute, Department of Medicine, Université de Montréal, 5000 Belanger, Montreal, QC, Canada H1T 1C8.
Lena RivardCardiovascular Genetics Center, Montreal Heart Institute, Department of Medicine, Université de Montréal, 5000 Belanger, Montreal, QC, Canada H1T 1C8.ORCID 0000-0002-1340-0850
Christopher S SimpsonDepartment of Medicine, Queen's University, Kingston, ON, Canada.ORCID 0000-0003-2411-219X
Martin GardnerQueen Elizabeth II Health Sciences Center, Halifax, NS, Canada.ORCID 0000-0001-9028-3478
Ciorsti MacIntyreQueen Elizabeth II Health Sciences Center, Halifax, NS, Canada.
Colette SeiferSt Boniface Hospital, University of Manitoba, Winnipeg, MB, Canada.
Anne FournierSte-Justine Hospital, Université de Montréal, Montreal, QC, Canada.
Jacqueline JozaDepartment of Medicine, McGill University Health Center, Montreal, QC, Canada.ORCID 0000-0003-0956-688X
Michael H GollobDivision of Cardiology, University Health Network, Toronto General Hospital, Toronto, ON, Canada.ORCID 0000-0003-0242-5208
Guillaume LettreCardiovascular Genetics Center, Montreal Heart Institute, Department of Medicine, Université de Montréal, 5000 Belanger, Montreal, QC, Canada H1T 1C8.ORCID 0000-0002-7740-3399
Mario TalajicCardiovascular Genetics Center, Montreal Heart Institute, Department of Medicine, Université de Montréal, 5000 Belanger, Montreal, QC, Canada H1T 1C8.ORCID 0000-0001-8469-4748
Zachary W LaksmanCenter for Cardiovascular Innovation, Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-7790-541X
Jason D RobertsPopulation Health Research Institute, McMaster University, and Hamilton Health Sciences, Hamilton, ON, Canada.
Andrew D KrahnCenter for Cardiovascular Innovation, Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-7982-1586
Rafik TadrosCardiovascular Genetics Center, Montreal Heart Institute, Department of Medicine, Université de Montréal, 5000 Belanger, Montreal, QC, Canada H1T 1C8.ORCID 0000-0002-1472-0258
Montreal Heart Institute · CAUniversity of British Columbia · CAWestern University · CAQueen Elizabeth II Health Sciences Centre · CAUniversity of Ottawa · CABC Children's Hospital · CAInstitut universitaire de cardiologie et de pneumologie de Québec · CAMcGill University Health Centre · CAPopulation Health Research Institute · CAQueen's University · CARoyal Jubilee Hospital · CASt. Boniface Hospital · CASt. Michael's Hospital · CAUniversité de Montréal · CAUniversity Health Network · CA

Funding

CIHR
6 · The paper itself

Abstract

aimsGenetic testing is recommended in specific inherited heart diseases but its role remains unclear and it is not currently recommended in unexplained cardiac arrest (UCA). We sought to assess the yield and clinical utility of genetic testing in UCA using whole-exome sequencing (WES). METHODS AND

resultsSurvivors of UCA requiring external defibrillation were included from the Cardiac Arrest Survivor with Preserved Ejection fraction Registry. Whole-exome sequencing was performed, followed by assessment of rare variants in previously reported cardiovascular disease genes. A total of 228 UCA survivors (mean age at arrest 39 ± 13 years) were included. The majority were males (66%) and of European ancestry (81%). Following advanced clinical testing at baseline, the likely aetiology of cardiac arrest was determined in 21/228 (9%) cases. Whole-exome sequencing identified a pathogenic or likely pathogenic (P/LP) variant in 23/228 (10%) of UCA survivors overall, increasing the proportion of 'explained' cases from 9% only following phenotyping to 18% when combining phenotyping with WES. Notably, 13 (57%) of the 23 P/LP variants identified were located in genes associated with cardiomyopathy, in the absence of a diagnosis of cardiomyopathy at the time of arrest.

conclusionsGenetic testing identifies a disease-causing variant in 10% of apparent UCA survivors. The majority of disease-causing variants was located in cardiomyopathy-associated genes, highlighting the arrhythmogenic potential of such variants in the absence of an overt cardiomyopathy diagnosis. The present study supports the use of genetic testing including assessment of arrhythmia and cardiomyopathy genes in survivors of UCA.

Indexed as

CardiomyopathiesHeart ArrestArrhythmias, CardiacFemaleGenetic TestingHeartHumansMaleArrhythmiaCardiac arrestCardiomyopathyCardiovascular geneticsGenetic testingVentricular fibrillation

Identifiers

PMID35352813
PMCPMC9392649
OpenAlexW4221014593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.